Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(99)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(123)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(31)
- Cat.No. 产品名称 Information
-
GC14411
Apoptozole
Apoptosis Activator VII
An inhibitor of Hsp70 -
GC14016
Sulforaphane
萝卜硫素
萝卜硫素 (SFN) 称为 [1-isothiocyanato-4-(methylsulfinyl)butane]。
-
GC16625
CDDO-TFEA
CDDO-Trifluoethyl Amide,RTA 404,TP-500
A synthetic triterpenoid with potent anticancer and neuroprotective activity -
GC17119
8-Prenylnaringenin
8-异戊烯基柚皮素
A phytoestrogen -
GC12639
NS3694
Apoptosis Inhibitor II
An inhibitor of apoptosome formation and caspase activation -
GC16375
(±)-Jasmonic Acid methyl ester
甲基茉莉酮酸酯,(±)-Methyl Jasmonate
A plant growth regulator -
GC11988
15-acetoxy Scirpenol
15-乙酰蛇形菌素
A trichothecene mycotoxin -
GC10661
Destruxin B
黑僵菌素 B
An insecticidal mycotoxin -
GC15225
COTI-2
An activator of mutant forms of p53
-
GC11989
Nortriptyline (hydrochloride)
盐酸去甲替林; Desmethylamitriptyline hydrochloride; Desitriptilina hydrochloride
A tricyclic antidepressant -
GC13194
RPI-1
A RET kinase inhibitor
-
GC14355
CRT5
CRT0066051
A pan PKD inhibitor -
GC10022
SP 141
6-甲氧基-1-(萘-1-基)-9H-吡啶并[3,4-B]吲哚,AGN-PC-0D106I
An inhibitor of MDM2 -
GC17649
Mebendazole
甲苯咪唑
A broad-spectrum anthelmintic that inhibits microtubules -
GC15812
p-nitro-Pifithrin-α
p-nitro-PFT-α
A cell-permeable inactivator of p53 -
GC16661
Citrinin
桔霉素; NSC 186
Citrinin是一种具有多种生物活性的霉菌毒素,由青霉属、曲霉属和红曲霉属的几种真菌菌株产生。 -
GC16409
Oligomycin B
寡霉素 B
A nonselective inhibitor of the mitochondrial F1FO ATP synthase -
GC10040
Arylquin 1
A Par-4 secretagogue
-
GC16362
AD57 (hydrochloride)
A polypharmacological cancer therapeutic
-
GC15880
Penicillic Acid
青霉酸,NSC 402844
A mycotoxin that inhibits quorum sensing -
GC16350
Actinonin
放线酰胺素,(-)-Actinonin,Ro 06-1467
An aminopeptidase inhibitor -
GC16823
Enniatin Complex
恩镰孢菌素复合物
A complex mixture of ionophores -
GC14050
MPI-0441138
EP128265
A potent inducer of apoptosis and growth inhibition -
GC10601
Ubiquitin Isopeptidase Inhibitor I
NSC 144303
An activator of caspases -
GC12545
2-HBA
Bis(2-hydroxybenzylidene)acetone
An indirect inhibitor of Keap1-Nrf2 interactions -
GC15394
CBL0137 (hydrochloride)
CBL0137盐酸盐,CBLC137,Curaxin 137
An activator of p53 and inhibitor of NF-κB -
GC14634
CBL0137
CBLC137,Curaxin 137
An activator of p53 and inhibitor of NF-κB -
GC17287
Iberin
3-甲基亚磺酰丙基异硫氰酸酯,NSC 321801
A natural isothiocyanate
-
GC11659
R-7050
TNF-α Antagonist III
R-7050 是一种新型细胞渗透性三唑并喹喔啉化合物,可选择性抑制 TNF-α;诱导细胞信号传导。 -
GC15710
ML-354
VU0099704
A PAR4 antagonist -
GC12124
Selonsertib (GS-4997)
GS-4997
An ASK1 inhibitor -
GC17023
HLCL-61
A PRMT5 inhibitor
-
GC13630
MK-4101
5-(3,3-二氟环丁基)-3-[4-[4-甲基-5-[2-(三氟甲基)苯基]-4H-1,2,4-三唑-3-基]双环[2.2.2]辛烷-1-基]-1,2,4-恶二唑
A Smoothened receptor antagonist -
GC15946
ReACp53
ReACp53 可以抑制 p53 淀粉样蛋白的形成并挽救癌细胞系中的 p53 功能。
-
GC15573
GSK481
A selective inhibitor of RIP1
-
GC16258
PD-1/PD-L1 Inhibitor 3
A PD-1/PD-L1 interaction inhibitor
-
GC16151
NSC348884
N1,N1,N2,N2-四[(6-甲基-1H-苯并咪唑-2-基)甲基]-1,2-乙二胺
A nucleophosmin inhibitor -
GC15282
LOXO-101 (Larotrectinib) sulfate
(3S)-N-[5-[(2R)-2-(2,5-二氟苯基)-1-吡咯烷基]吡唑并[1,5-A]嘧啶-3-基]-3-羟基-1-吡咯烷甲酰胺硫酸盐,LOXO-101 sulfate; ARRY-470 sulfate
A pan-Trk inhibitor -
GC15142
PD-1/PD-L1 inhibitor 1 (BMS-1)
BMS-1
PD-1/PD-L1 inhibitor 1 是一种 PD-1/PD-L1 相互作用抑制剂,IC50 值介于 6 和 100 nM . PD-1/PD-L1 调节细胞信号通路和表观遗传修饰,从而抑制 T 细胞和 B 细胞的增殖和效应子功能。 -
GC13648
CC-223
CC-223; ATG-008
A potent, selective inhibitor of mTOR -
GC16039
LJH685
2,6-二氟-4-[4-[4-(4-甲基-1-哌嗪基)苯基]-3-吡啶基]苯酚
An inhibitor of RSKs -
GC11837
MI-136
A menin-MLL inhibitor
-
GC17513
A-1331852
A Bcl-xL inhibitor
-
GC17512
A-1155463
醋酸艾塞那肽
A Bcl-xL inhibitor -
GC12962
Isatin
靛红,Indoline-2,3-dione
Isatin (Indoline-2,3-dione) 是一种有效的单胺氧化酶 (MAO) 抑制剂,IC50 为 3 μM。 -
GC16517
Eugenol
丁香酚
丁香酚是一种存在于丁香中的精油,具有抗菌、驱虫和抗氧化活性。 -
GC10855
Etretinate
依曲替酯; Ro 10-9359
A second-generation retinoid -
GC11935
Escin
七叶皂苷
七叶皂苷是一种从七叶树 (Aesculus hippocastanum) 种子中分离出来的三萜皂苷的天然化合物,可用作血管保护性抗炎、抗水肿和抗伤害剂。 -
GC14500
CPI-1189
N-叔丁基-4-乙酰氨基苯甲酰胺
A benzamide -
GC14503
IC261
SU5607
A reversible inhibitor of CK1